Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide

Clin Exp Rheumatol. 2005 Sep-Oct;23(5):724.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Cyclophosphamide / administration & dosage*
  • Dermatomyositis / complications*
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Lung Diseases, Interstitial / drug therapy*
  • Lung Diseases, Interstitial / etiology
  • Male
  • Middle Aged
  • Polymyositis / complications*
  • Pulse Therapy, Drug
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide